Risk and Outcomes of Secondary Cancer Among Lung Cancer Survivors After Definitive Treatment
In this cohort study of NSCLC survivors, the risk of NLSC was clinically meaningful and distinct from intrathoracic new cancers. Genetic predisposition correlated with NLSC risk and should inform survivorship care pathways.
Authors
- Narek Shaverdian (ORCID: https://orcid.org/0000-0002-0294-8749)
- Puneeth Iyengar (ORCID: https://orcid.org/0000-0003-3740-7915)
- Sana Raoof (ORCID: https://orcid.org/0000-0003-2977-8687)
- Bernard J. Park
- Bob T. Li (ORCID: https://orcid.org/0000-0001-6661-8733)
- David R. Jones (ORCID: https://orcid.org/0000-0002-3318-0146)
- Orly Yariv (ORCID: https://orcid.org/0000-0002-1268-8645)
- Jamie E. Chaft (ORCID: https://orcid.org/0000-0002-5838-9982)
- Daniel R. Gomez (ORCID: https://orcid.org/0000-0002-1839-9510)
- Matthew T. McMillan (ORCID: https://orcid.org/0000-0003-0519-2577)
- Unjeria Jackson
- Julianne Ruggiero
Institutions
- Memorial Sloan Kettering Cancer Center (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.47831
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00